Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome

Published:2017-07-05 Issue:8 Volume:69 Page:1679-1688
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Arostegui Juan I.¹,Anton Jordi²,Calvo Inmaculada³,Robles Angel⁴,Iglesias Estibaliz²,López-Montesinos Berta³,Banchereau Romain⁵,Hong Seunghee⁵,Joubert Yolandi⁶,Junge Guido⁶,Pascual Virginia⁷,Yagüe Jordi¹

Affiliation:

1. Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer; Barcelona Spain

2. Hospital Sant Joan de Déu; Esplugues Spain

3. Hospital Universitario La Fe; Valencia Spain

4. Hospital Universitario La Paz; Madrid Spain

5. Baylor Institute for Immunological Research; Dallas Texas

6. Novartis Pharma AG; Basel Switzerland

7. Baylor Institute for Immunological Research and Texas Scottish Rite Hospital for Children; Dallas Texas

Funder

Novartis Pharma

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.40146/fullpdf

Reference42 articles.

1. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome;Houten;Nat Genet,1999

2. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome;Drenth;Nat Genet,1999

3. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome;Hilst;Medicine (Baltimore),2008

4. The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever Registry;Ter Haar;Arthritis Rheumatol,2016

5. Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency;Galeotti;Rheumatology (Oxford),2012

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D clustering of gene expression data from systemic autoinflammatory diseases using self-organizing maps (Clust3D);Computational and Structural Biotechnology Journal;2024-12

2. Long-term safety profile and secondary effectiveness of canakinumab in pediatric rheumatic diseases: a single-center experience;Expert Opinion on Drug Safety;2024-08

3. Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA);Pediatric Drugs;2024-02-20

4. A case of neonatal sweet syndrome associated with mevalonate kinase deficiency;Pediatric Rheumatology;2023-09-12

5. A Case of Neonatal Sweet Syndrome Associated with Mevalonate Kinase Deficiency;2023-05-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3